| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.22 | 8e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.21 | 0.0007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.1 | 0.08 |